Age-Related Changes in Body Composition
Age-Associated Changes in Regional Adiposity and Novel Cardiovascular Risk Factors
2 other identifiers
observational
24
1 country
2
Brief Summary
Background: \- Advancing age is associated with greater risk of heart disease. High blood pressure and hardening of the arteries also have more complications with age. Studies suggest that age-related inflammation may affect fatty tissue in the body. If this fat develops in the muscles or around the heart, it may increase risks of heart disease. Researchers will study body composition in older adults to see if age-related changes in body fat are related to higher risks of heart disease. Objectives: \- To study the relationship between fat deposits and aging, and greater risks of heart disease. Eligibility:
- Participants in the Baltimore Longitudinal Study of Aging between 50 and 80 years of age.
- Individuals between 50 and 80 years of age who have been diagnosed with coronary artery disease. Design:
- Participants will be screened with a physical exam and medical history.
- Participants will provide blood and urine samples. They will also have their height and weight measured. Waist circumference will also be taken.
- Participants will have a DEXA scan to study their muscles.
- Participants will have magnetic resonance imaging scans. These scans will study heart function and muscle and blood vessel health.
- Participants with coronary artery disease will have catheterization. Blood samples will be collected during the procedure....
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2012
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 2, 2012
CompletedFirst Submitted
Initial submission to the registry
January 24, 2012
CompletedFirst Posted
Study publicly available on registry
January 25, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
October 13, 2017
CompletedApril 5, 2018
October 13, 2017
January 24, 2012
April 4, 2018
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Age 50-90 years
- Body mass index greater than or equal to 20 and less than or equal to 35
- Weight is less than 300 lbs
- In addition, for CAD participants (Group B):
- Catheterization-documented coronary artery disease, defined as greater than or equal to 70% stenosis in a major epicardial coronary artery, or greater than or equal to 50% stenosis of the left main coronary artery OR
- Prior myocardial infarction defined by ischemic symptoms associated with ECG changes and enzyme elevation.
- In addition, for CAD participants in whom arterial and hepatic vein inflammatory mediators will be obtained:
- \- Scheduled for clinically indicated right or left heart catheterization, no contraindication for the procedure, and consented to the research procedure.
You may not qualify if:
- Known inflammatory disease
- Known liver disease
- Abnormal liver function tests defined by enzyme rise to greater than three times the upper limit of normal.
- Contraindications to the performance of MRI scans
- Chronic use of anti-inflammatory agents other than low dose aspirin (81mg). Chronic use is defined here as the inability to stop taking their anti-inflammatory agent for at least one week before starting this study
- Pregnant or lactating
- In addition, for BLSA participants:
- \- Known coronary artery disease by prior history, examination, or resting or stress electrocardiogram testing.
- In addition, for CAD participants undergoing arterial and hepatic vein inflammatory mediator sampling:
- Receiving therapy with heparin, a glycoprotein IIB/IIIA inhibitor, or bivalirudin
- History of atrial fibrillation
- Presence of an inferior vena cava filter
- Deep venous thrombosis
- Active infection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Johns Hopkins University
Baltimore, Maryland, 21205, United States
National Institute of Aging, Clinical Research Unit
Baltimore, Maryland, 21224, United States
Related Publications (3)
Singh T, Newman AB. Inflammatory markers in population studies of aging. Ageing Res Rev. 2011 Jul;10(3):319-29. doi: 10.1016/j.arr.2010.11.002. Epub 2010 Dec 8.
PMID: 21145432BACKGROUNDFerrucci L, Corsi A, Lauretani F, Bandinelli S, Bartali B, Taub DD, Guralnik JM, Longo DL. The origins of age-related proinflammatory state. Blood. 2005 Mar 15;105(6):2294-9. doi: 10.1182/blood-2004-07-2599. Epub 2004 Nov 30.
PMID: 15572589BACKGROUNDBrooks GC, Blaha MJ, Blumenthal RS. Relation of C-reactive protein to abdominal adiposity. Am J Cardiol. 2010 Jul 1;106(1):56-61. doi: 10.1016/j.amjcard.2010.02.017. Epub 2010 May 13.
PMID: 20609648BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luigi Ferrucci, M.D.
National Institute on Aging (NIA)
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 24, 2012
First Posted
January 25, 2012
Study Start
January 2, 2012
Study Completion
October 13, 2017
Last Updated
April 5, 2018
Record last verified: 2017-10-13